Form EFFECT Astria Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 27, 2026 |
| Accession Number: | 0001140361-26-002203 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Great Western Mining Corporation PLC Announces Holding(s) in Company
- Goodix Launches Integrated Fingerprint and Security Solution to Secure On-Device Identity Authentication in IoT and AI Devices
- Volta More than Doubles Springer Indicated Resource to 122.4 Mt, Ranks Among North America's Five Largest Rare Earth Deposits by M&I Tonnage*, and Delivers First Gallium Estimate
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share